🔴 Intervacc is trading 20.14% down — no clear company-specific explanation identified

Intervacc is trading at €0.05, down -20.14%, with no clear company-specific explanation identified for the November 5 decline.

• Intervacc’s November 3 Strangvac update reported three confirmed infections among horses completing primary vaccination after 100,000 doses were sold; this was positive news, not an evident explanation for the drop.
• The provided sector context showed biotech strength, which does not explain the opposite-direction move.
• Trading volume information was unavailable.